Question explored with the scientific record
Conversation so far
- 1 Do all flu vaccines now contain MRNA
- 2 Do all vaccines contain aluminium
Answered on this page ↓
Do all vaccines contain aluminium
The short version: no, not all vaccines contain aluminum. Many do, but several common ones do not.
The evidence here is mostly about how aluminum adjuvants work in the vaccines that contain them [6, 9], not about which vaccines contain them. A 2018 review lists the standard aluminum forms as aluminum hydroxide, aluminum phosphate, and amorphous aluminum hydroxyphosphate sulfate [6]. These are used in vaccines like DTaP, Hib, hepatitis B, HPV, and pneumococcal conjugates [6, 8]. But the evidence also describes vaccines formulated without aluminum: a meningococcal B proteoliposome vaccine that worked without it [5], and a pertussis proteoliposome that used it but was compared to a whole-cell DTP that also contained it [7]. The rotavirus vaccine studied in Ghana is a live oral vaccine and contains no aluminum [11]. The MMR vaccine is live attenuated and contains no aluminum [10]. The BCG vaccine is live and contains no aluminum [10].
So the split is roughly by vaccine type. Inactivated and subunit vaccines (shots that use killed virus or pieces of it) often need an adjuvant to provoke a strong immune response, and aluminum is the oldest and cheapest one [9]. Live attenuated vaccines (measles, mumps, rubella, rotavirus, BCG, nasal flu) do not need an adjuvant because the live virus itself triggers the immune system. The mRNA and viral-vector vaccines (some COVID-19 shots, some flu candidates in development) use lipid nanoparticles or other delivery systems instead of aluminum [1, 2, 4].
| Vaccine type | Contains aluminum? | Examples from evidence |
|---|---|---|
| Inactivated/subunit (adjuvanted) | Yes, most | DTaP, Hib, hepatitis B, HPV, pneumococcal [6, 8] |
| Live attenuated | No | MMR, rotavirus, BCG [10, 11] |
| mRNA/viral vector | No | COVID-19, some flu candidates [1, 2, 4] |
| Recombinant protein | Sometimes | Some hepatitis B, some flu [3] |
The evidence does not give a complete list of every vaccine and its ingredients. But the pattern is clear from the studies here: aluminum is in the shots that need a kick to the immune system, not in the ones that already have one built in. If you want to know whether a specific vaccine contains aluminum, the package insert will list it under "adjuvant" or "aluminum hydroxide/phosphate."
My call: many vaccines contain aluminum, but not all. The live vaccines and the newer mRNA vaccines do not. Confidence: high.
Sources used 11
-
Poly-∊-caprolactone/chitosan Nanoparticles Provide Strong Adjuvant Effect for Hepatitis B Antigen
This study investigates the adjuvant effect of poly-ε-caprolactone/chitosan nanoparticles on hepatitis B surface antigen and plasmid DNA encoding HBsAg, demonstrating enhanced immune responses in C57BL/6 mice.
DOI: 10.2217/nnm-2017-0138 -
Protection of aluminum hydroxide during lyophilisation as an adjuvant for freeze-dried vaccines
This study investigates the stabilization of aluminum hydroxide adjuvants in vaccine formulations during lyophilization, demonstrating that specific excipients like trehalose and dextran can effectively maintain the adjuvant's properties under freeze-drying conditions.
DOI: 10.1016/j.colsurfa.2008.07.031 -
Start-Up and Validation of Sterile Formulation and Filling Processes for the Manufacture of Parenteral Aluminum Hydroxide-Based Vaccines
This study details the start-up and validation processes for the sterile formulation and filling of aluminum hydroxide-based vaccines, emphasizing the challenges and methodologies involved in ensuring product sterility and efficacy.
DOI: 10.1021/bk-1998-0698.ch011 -
Simultaneous enhancement of cellular and humoral immunity by the high salt formulation of Al(OH)3 adjuvant
This study demonstrates that a high salt formulation of aluminum hydroxide (Al(OH)3) adjuvant enhances both cellular and humoral immunity, leading to improved vaccine efficacy against tumors in mouse models.
DOI: 10.1038/cr.2017.14 -
New proteoliposome vaccine formulation from N. meningitidis serogroup B, without aluminum hydroxide, retains its antimeningococcal protectogenic potential as well as Th-1 adjuvant capacity
Defined proteoliposomal vaccine formulation from Neisseria meningitidis B without aluminum hydroxide induces Th1-biased cellular immunity and protective antimeningococcal antibodies in BALB/c mice, with immunogenicity and bactericidal activity comparable to aluminum-adjuvanted V…
DOI: 10.1186/1471-2172-14-s1-s12 -
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
This article reviews aluminum-containing vaccine adjuvants (AH, AP, AAHS, Imject Alum), their physicochemical properties, antigen–adjuvant interactions, formulation strategies, mechanisms of action, and benchmarks for evaluating newer adjuvants against the established aluminum s…
DOI: 10.1038/s41541-018-0089-x -
A Bordetella pertussis proteoliposome induces protection in mice without affecting the immunogenicity of diphtheria and tetanus toxoids in a trivalent formulation
A murine study evaluating a trivalent formulation of Bordetella pertussis proteoliposome (PLBp) with diphtheria and tetanus toxoids in BALB/c mice, showing protection against intranasal pertussis challenge without compromising toxoid immunogenicity.
DOI: 10.7774/cevr.2016.5.2.175 -
Preclinical Immunogenicity Evaluation of a DTacP-sIPV/Hib Combination Vaccine in Rodent Models Under Varying Formulations and Immunization Schedules
Preclinical evaluation in NIH mice and Wistar rats of a DTacP-sIPV/Hib pentavalent vaccine candidate to optimize Hib dose, Sabin IPV formulations, and immunization schedules, showing robust immunogenicity across schedules and administration methods with a recommended formulation…
DOI: 10.3390/vaccines13100993 -
Chemical and Immunological Characteristics of Aluminum-Based, Oil-Water Emulsion, and Bacterial-Origin Adjuvants
This minireview summarizes chemical and immunological characteristics of the main vaccine adjuvant classes—aluminum-based, oil-water emulsions, and bacterial-origin adjuvants—and discusses how adjuvant choice influences immunogenicity and safety for different vaccines.
DOI: 10.1155/2019/3974127 -
Routine childhood vaccination programme coverage, El Salvador, 2011—In search of timeliness
This study assessed vaccination coverage and timeliness for routine childhood vaccinations in El Salvador, revealing high overall coverage but significant delays in timely vaccination, particularly for the rotavirus vaccine.
DOI: 10.1016/j.vaccine.2013.11.072 -
A health surveillance data-based assessment of the impact of routine paediatric rotavirus vaccination on all-cause acute childhood diarrhoea
Routine rotavirus vaccination in Ghana was followed by marginal but sustained declines in childhood acute diarrhoea among children aged 1 month to 4 years (2016-2021), though regional effects were inconsistent and similar declines in unvaccinated infants complicate interpretatio…
DOI: 10.46829/hsijournal.2023.6.4.1.435-442